Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2009, Article ID 717545, 4 pages
http://dx.doi.org/10.1155/2009/717545
Case Report

A Case of Neonatal Neutropenia Due to Anti-Fc Gamma Receptor IIIb Isoantibodies Treated with Recombinant Human Granulocyte Colony Stimulating Factor

1Department of Platelet and Leukocyte Immunology, Croatian Institute of Transfusion Medicine, HR-10000 Zagreb, Croatia
2Department of Neonatology, University Department of Pediatrics, Sestre Milosrdnice University Hospital, HR-10000 Zagreb, Croatia
3Department of Molecular Immunogenetics, Croatian Institute of Transfusion Medicine, HR 10000, Zagreb, Croatia
4Department of Immunohematology, Croatian Institute of Transfusion Medicine, HR 10000, Zagreb, Croatia

Received 8 June 2009; Accepted 18 July 2009

Academic Editor: Frans J. Walther

Copyright © 2009 Maja Tomicic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Maheshwari, R. D. Christensen, and D. A. Calhoun, “Immune-mediated neutropenia in the neonate,” Acta Paediatrica, vol. 91, no. 438, pp. 98–103, 2002. View at Google Scholar
  2. J. Bux, K. D. Jung, T. Kauth, and C. Mueller-Eckhardt, “Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia,” Transfusion Medicine, vol. 2, no. 2, pp. 143–149, 1992. View at Google Scholar
  3. J. Bux, “Granulocyte immunology,” Wiener Klinische Wochenschrift, vol. 113, no. 20-21, pp. 799–805, 2001. View at Google Scholar
  4. M. De Haas, M. Kleijer, R. van Zwieten, D. Roos, and A. E. von dem Borne, “Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families,” Blood, vol. 86, no. 6, pp. 2403–2413, 1995. View at Google Scholar
  5. J. Bux, “Human neutrophil alloantigens,” Vox Sanguinis, vol. 94, no. 4, pp. 277–285, 2008. View at Publisher · View at Google Scholar
  6. C. Press, W. E. Kline, M. E. Clay, and J. McCullough, “A microtiter modification of granulocyte immunofluorescence,” Vox Sanguinis, vol. 49, no. 2, pp. 110–113, 1985. View at Google Scholar
  7. J. Bux, B. Kober, V. Kiefel, and C. Mueller-Eckhardt, “Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigens,” Transfusion Medicine, vol. 3, no. 2, pp. 157–162, 1993. View at Google Scholar
  8. K. Yasui, T. Miyazaki, N. Matsuyama et al., “Establishment of cell lines stably expressing HNA-1a, -1b, and -2a antigen with low background reactivity in flow cytometric analysis,” Transfusion, vol. 47, no. 3, pp. 478–485, 2007. View at Publisher · View at Google Scholar
  9. P. Lalezari and E. Radel, “Neutrophil specific antigens: immunology and clinical significance,” Seminars in Hematology, vol. 11, no. 3, pp. 281–290, 1974. View at Google Scholar
  10. B. K. Flesch, S. Doose, R. Siebert, E. Ntambi, and J. Neppert, “FCGR3 variants and expression of human neutrophil antigen-1a, -1b, and -1c in the populations of northern Germany and Uganda,” Transfusion, vol. 42, no. 4, pp. 469–475, 2002. View at Google Scholar
  11. J. Bux, E. L. Stein, S. Santoso, and C. Mueller-Eckhardt, “NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers,” Transfusion, vol. 35, no. 1, pp. 54–57, 1995. View at Google Scholar
  12. T. Hanada, R. Shin, M. Hosoi, K. Saito, and H. Takita, “Intravenous gammaglobulin in treatment of isoimmune neonatal neutropenia,” European Journal of Pediatrics, vol. 148, no. 3, pp. 218–219, 1988. View at Google Scholar
  13. A. Maheshwari, R. D. Christensen, and D. A. Calhoun, “Resistance to recombinant human granulocyte colony-stimulating factor in neonatal alloimmune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies,” Pediatrics, vol. 109, no. 4, article e64, 2002. View at Google Scholar
  14. M. M. Gilmore, D. F. Stroncek, and D. N. Korones, “Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor,” Journal of Pediatrics, vol. 125, no. 6, pp. 948–951, 1994. View at Publisher · View at Google Scholar
  15. P. Girlando, A. A. Zuppa, C. Romagnoli, and G. Tortorolo, “Transient effect of granulocyte colony-stimulating factor in allo-immune neonatal neutropenia,” Biology of the Neonate, vol. 78, no. 4, pp. 277–280, 2000. View at Google Scholar
  16. T. W. Huizinga, R. W. Kuijpers, M. Kleijer et al., “Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia,” Blood, vol. 76, no. 10, pp. 1927–1932, 1990. View at Google Scholar
  17. P. Fromont, A. Bettaieb, H. Skouri et al., “Frequency of the polymorphonuclear neutrophil Fc? receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia,” Blood, vol. 79, no. 8, pp. 2131–2134, 1992. View at Google Scholar
  18. K. Maślanka, K. Guz, M. Uhrynowska, and B. Zupańska, “Isoimmune neonatal neutropenia due to anti-Fcgamma RIIIb antibody in a mother with an Fcgamma RIIIb deficiency,” Transfusion Medicine, vol. 11, no. 2, pp. 111–113, 2001. View at Publisher · View at Google Scholar
  19. N. Puig, M. de Haas, M. Kleijer et al., “Isoimmune neonatal neutropenia caused by Fc gamma RIIIb antibodies in a Spanish child,” Transfusion, vol. 35, no. 8, pp. 683–687, 1995. View at Google Scholar
  20. B. A. Williams and Y. L. Fung, “Alloimmune neonatal neutropenia: can we afford the consequences of a missed diagnosis?” Journal of Paediatrics and Child Health, vol. 42, no. 1-2, pp. 59–61, 2006. View at Publisher · View at Google Scholar
  21. D. Anderson, K. Ali, V. Blanchette et al., “Guidelines on the use of intravenous immune globuline for hematologic conditions,” Transfusion Medicine Reviews, vol. 21, supplement 1, pp. S9–S56, 2007. View at Google Scholar
  22. G. Latini, A. Del Vecchio, E. Rosati, P. Borzini, G. Chirico, and G. Rondini, “Different responses to granulocyte colony-stimulating factor treatment in siblings with alloimmune neonatal neutropenia,” Acta Paediatrica, vol. 88, no. 12, pp. 1407–1409, 1999. View at Google Scholar
  23. D. F. Stroncek, R. S. Shapiro, A. H. Filipovich, L. B. Plachta, and M. E. Clay, “Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation,” Transfusion, vol. 33, no. 2, pp. 158–163, 1993. View at Google Scholar
  24. S. Wicki, A. Keisker, C. Aebi, K. Leibundgut, A. Hirt, and R. A. Ammann, “Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?” Pediatric Blood and Cancer, vol. 51, no. 6, pp. 778–783, 2008. View at Publisher · View at Google Scholar
  25. G. Carlsson, A. A. Aprikyan, K. G. Ericson et al., “Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden,” Haematologica, vol. 91, no. 5, pp. 589–595, 2006. View at Google Scholar
  26. M. Kikkawa, S. Matsubara, M. Takatoku et al., “Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia,” Journal of Obstetrics and Gynaecology Research, vol. 34, no. 2, pp. 286–290, 2008. View at Publisher · View at Google Scholar